FindTrial
Sign In

Eye changes review in Eye tissue

Multi-omics Strategies to Improve Clinical Outcomes in Uveitis LOTUS – Leveraging Ocular Tissues in Uveitis Study - LOTUS

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/11/077473
Enrollment
600
Registered
2024-11-28
Start date
Unknown
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H578- Other specified disorders of eye and adnexa

Interventions

Intervention1: Nil: Not applicable Control Intervention1: Nil: Not Applicable

Sponsors

Proctor Foundation University of California
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Intraocular samples a) Presumed active infectious uveitis b) Endophthalmitis c) Unilateral or Bilateral Tear samples a) Active or inactive uveitis b) Unilateral or Bilateral

Exclusion criteria

Exclusion criteria: Intraocular samples a) Insufficient sample size b) Inability to give consent Tear samples a) Inability to give consent

Design outcomes

Primary

MeasureTime frame
Correct identification of the pathogen will change the treatment modalityTimepoint: 3 months—

Secondary

MeasureTime frame
NilTimepoint: Not applicable—

Countries

India, United States of America

Contacts

Public ContactDr Rathinam Sivakumar

Aravind Eye Hospital and Postgraduate Institute of Ophthalmology

rathinam@aravind.org914524356100

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026